Towa Yakuhin KK
4553
ISIN JP3623150004 / Valor 248084
Towa Yakuhin KK
UMushroom community rating:
About company
Towa Yakuhin KK is a Japanese pharmaceutical company specializing in the development, manufacturing, and distribution of generic drugs.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (14.08.2024):
Net Sales
Towa Yakuhin KK reported net sales of 227,934 million yen for the fiscal year ending March 31, 2024. This represents an increase from the previous fiscal year's net sales of 208,859 million yen.
Operating Profit
For the fiscal year ending March 31, 2024, Towa Yakuhin KK achieved an operating profit of 17,647 million yen. This is a significant improvement compared to the 5,514 million yen recorded in the previous fiscal year.
Ordinary Profit
Towa Yakuhin KK's ordinary profit for the fiscal year ending March 31, 2024, was 24,477 million yen. This marks a substantial increase from the 5,141 million yen reported in the prior fiscal year.
Profit Attributable to Owners
The profit attributable to owners of Towa Yakuhin KK for the fiscal year ending March 31, 2024, was 16,173 million yen. This is a notable rise from the 2,201 million yen reported in the previous fiscal year.
Earnings Per Share
Towa Yakuhin KK reported earnings per share of 328.59 yen for the fiscal year ending March 31, 2024. This is a significant increase from the 44.72 yen per share reported in the previous fiscal year.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
1079 M
Market cap (USD)
56,200
Daily traded volume (Shares)
2975 / 2929
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
